Lupin's

Meanwhile, Lupin's U.S. generics business has faced uncertainty over the launch of copies of a lucrative portfolio of oral contraceptives.

Lupin Expects Better Operating Margin in Two Years Rumman Ahmed 2011

As a result of the drop in profitability, Lupin's stock has lost almost 10% of its market value since the beginning of 2011 and 16% since Nov. 30, 2010, when it hit a 52-week high of 519.80 rupees.

Lupin Expects Better Operating Margin in Two Years Rumman Ahmed 2011

Lupin's margins have been under pressure due to high research expenses and an increase in overhead costs related to a new facility located in a special enclave that enjoys tax breaks at Indore in central India.

Lupin Expects Better Operating Margin in Two Years Rumman Ahmed 2011

Rather, it's Lupin's conviction to protect Harry at all costs, his sense of standing firm on his boundaries, and if necessary to use the boundary as a weapon.

Kelley Harrell: Harry Potter and the Elder Futhark Kelley Harrell 2011

Kyowa accounted for 11% of Lupin's consolidated sales of 57.07 rupees billion for the last financial year ended March 31.

Lupin to Buy Japanese Injectable Drugs Maker 2011

Mumbai-based Lupin's earnings before interest, tax, depreciation and amortization, or EBITDA, margin had slipped sequentially in the four quarters of the last fiscal year.

Lupin Expects Better Operating Margin in Two Years Rumman Ahmed 2011

JM Financial Institutional SecuritiesPvt. Ltd. in a research note in May forecast Lupin's EBITDA margin to contract to 20.1% in the current fiscal year from 20.6% last year.

Lupin Expects Better Operating Margin in Two Years Rumman Ahmed 2011

Rather, it's Lupin's conviction to protect Harry at all costs, his sense of standing firm on his boundaries, and if necessary to use the boundary as a weapon.

Kelley Harrell: Harry Potter and the Elder Futhark Kelley Harrell 2011

I didn't like the way that Tonks and Lupin's death was handled.

Harry Potter and the Deathly Hallows by J. K. Rowling 2007

Lupin's Suprax sales in the U.S. jumped to about $74 million for the financial year that ended March 31 from $41.2 million a year earlier.

Lupin Sees No Financial Impact from FDA Warning 2009